{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:8081"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:8081","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Characterisation of the cellular response to defective translational termination","abstract":"Enzymatic hydroxylation of varied cellular substrates is catalyzed by the 2-oxoglutarate and Fe(II) dependent 2-oxoglutrate (OG) oxygenase group of proteins. These enzymes control gene expression, from epigenetics to splicing and translation. The 2OG oxygenase JMJD4 has been shown to catalyse the hydroxylation of the eukaryotic omnipotent termination factor 1 (eRF1), and is essential for optimal translational termination. In this thesis, we expand on previous work by examining two further potential binding partners of JMJD4, GTF2I and TCP1-γ. Subsequently, we find that depletion of JMJD4 and eRF1 is associated with growth reduction in cancer cell lines in 2D and 3D. The transcriptomic changes in response to eRF1 depletion are then assessed by RNA-Seq. Among the potential pathways identified, downstream targets of the transcription factor ATF4 were most prominent. Upregulation of ATF4 and its downstream targets was validated in an eRF1 rescue system and the contribution of specific subdomains of eRF1 to the transcriptional response assessed, indicating multiple arms of the unfolded protein response being upregulated downstream of defective translational termination. The implications of our findings and their relevance in wider biological and disease contexts, including cancer, is finally discussed.","abstract_html":"Enzymatic hydroxylation of varied cellular substrates is catalyzed by the 2-oxoglutarate and Fe(II) dependent 2-oxoglutrate (OG) oxygenase group of proteins. These enzymes control gene expression, from epigenetics to splicing and translation. The 2OG oxygenase JMJD4 has been shown to catalyse the hydroxylation of the eukaryotic omnipotent termination factor 1 (eRF1), and is essential for optimal translational termination. In this thesis, we expand on previous work by examining two further potential binding partners of JMJD4, GTF2I and TCP1-γ. Subsequently, we find that depletion of JMJD4 and eRF1 is associated with growth reduction in cancer cell lines in 2D and 3D. The transcriptomic changes in response to eRF1 depletion are then assessed by RNA-Seq. Among the potential pathways identified, downstream targets of the transcription factor ATF4 were most prominent. Upregulation of ATF4 and its downstream targets was validated in an eRF1 rescue system and the contribution of specific subdomains of eRF1 to the transcriptional response assessed, indicating multiple arms of the unfolded protein response being upregulated downstream of defective translational termination. The implications of our findings and their relevance in wider biological and disease contexts, including cancer, is finally discussed.","abstract_has_math":false,"creators":["Ploumakis, Athanasios"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018-07","date_published":"2018-07","updated_at":"2026-11-19T09:29:44Z","subjects":["RB Pathology","RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/8081/1/Ploumakis18PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A8081","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Ploumakis, Athanasios"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2018-07"]},{"key":"dc:date.issued","label":"Date","values":["2018-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Cancer and Genomic Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/8081/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RB Pathology","RC0254 Neoplasms. Tumors. Oncology (including Cancer)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/8081/1/Ploumakis18PhD.pdf","http://etheses.bham.ac.uk//id/eprint/8081/2/Decl_IS_Ploumakis18PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Enzymatic hydroxylation of varied cellular substrates is catalyzed by the 2-oxoglutarate and Fe(II) dependent 2-oxoglutrate (OG) oxygenase group of proteins. These enzymes control gene expression, from epigenetics to splicing and translation. The 2OG oxygenase JMJD4 has been shown to catalyse the hydroxylation of the eukaryotic omnipotent termination factor 1 (eRF1), and is essential for optimal translational termination. In this thesis, we expand on previous work by examining two further potential binding partners of JMJD4, GTF2I and TCP1-γ. Subsequently, we find that depletion of JMJD4 and eRF1 is associated with growth reduction in cancer cell lines in 2D and 3D. The transcriptomic changes in response to eRF1 depletion are then assessed by RNA-Seq. Among the potential pathways identified, downstream targets of the transcription factor ATF4 were most prominent. Upregulation of ATF4 and its downstream targets was validated in an eRF1 rescue system and the contribution of specific subdomains of eRF1 to the transcriptional response assessed, indicating multiple arms of the unfolded protein response being upregulated downstream of defective translational termination. The implications of our findings and their relevance in wider biological and disease contexts, including cancer, is finally discussed."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["Characterisation of the cellular response to defective translational termination"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Ploumakis, Athanasios"],"dc:date":["2018-07"],"dc:date.issued":["2018-07"],"dc:description.abstract":["Enzymatic hydroxylation of varied cellular substrates is catalyzed by the 2-oxoglutarate and Fe(II) dependent 2-oxoglutrate (OG) oxygenase group of proteins. These enzymes control gene expression, from epigenetics to splicing and translation. The 2OG oxygenase JMJD4 has been shown to catalyse the hydroxylation of the eukaryotic omnipotent termination factor 1 (eRF1), and is essential for optimal translational termination. In this thesis, we expand on previous work by examining two further potential binding partners of JMJD4, GTF2I and TCP1-γ. Subsequently, we find that depletion of JMJD4 and eRF1 is associated with growth reduction in cancer cell lines in 2D and 3D. The transcriptomic changes in response to eRF1 depletion are then assessed by RNA-Seq. Among the potential pathways identified, downstream targets of the transcription factor ATF4 were most prominent. Upregulation of ATF4 and its downstream targets was validated in an eRF1 rescue system and the contribution of specific subdomains of eRF1 to the transcriptional response assessed, indicating multiple arms of the unfolded protein response being upregulated downstream of defective translational termination. The implications of our findings and their relevance in wider biological and disease contexts, including cancer, is finally discussed."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/8081/1/Ploumakis18PhD.pdf","http://etheses.bham.ac.uk//id/eprint/8081/2/Decl_IS_Ploumakis18PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Cancer and Genomic Sciences"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/8081/"],"dc:subject":["RB Pathology","RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"dcterms:accessrights":["public","staffonly"],"dc:title":["Characterisation of the cellular response to defective translational termination"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:29:44Z"}